• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

胆汁淤积性黄疸中的纤维蛋白溶解作用。

Fibrinolysis in cholestatic jaundice.

作者信息

Jedrychowski A, Hillenbrand P, Ajdukiewicz A B, Parbhoo S P, Sherlock S

出版信息

Br Med J. 1973 Mar 17;1(5854):640-2. doi: 10.1136/bmj.1.5854.640.

DOI:10.1136/bmj.1.5854.640
PMID:4120848
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1588651/
Abstract

The fibrinolytic system was studied in primary biliary cirrhosis (16 patients) and large bile duct obstruction (10 patients, nine of whom had carcinoma). Plasma fibrinolysis (plasminogen activator activity) was decreased and fibrinogen increased in both groups of patients, particularly in those with large duct obstruction. These changes were related to the degree of cholestasis. Plasminogen activator activity was inversely related to serum triglyceride levels in patients with primary biliary cirrhosis. Urokinase inhibitors were decreased in both groups and antiplasmins increased in patients with large duct obstruction; fibrin/fibrinogen degradation products were normal in primary biliary cirrhosis and moderately increased in large duct obstruction. None of these fibrinolytic indices was related to the degree of cholestasis. Fibrinolytic activity and fibrinogen returned almost to normal levels after palliative surgery in the three patients with large duct obstruction who were studied. The decreased plasma fibrinolysis and increased fibrinogen may be due to altered lipid metabolism in cholestatic jaundice. In patients undergoing surgery for large duct obstruction there may be an increased risk of thrombosis.

摘要

对原发性胆汁性肝硬化患者(16例)和大胆管梗阻患者(10例,其中9例患有癌症)的纤溶系统进行了研究。两组患者的血浆纤溶(纤溶酶原激活物活性)均降低,纤维蛋白原增加,尤其是大胆管梗阻患者。这些变化与胆汁淤积程度有关。在原发性胆汁性肝硬化患者中,纤溶酶原激活物活性与血清甘油三酯水平呈负相关。两组患者的尿激酶抑制剂均减少,大胆管梗阻患者的抗纤溶酶增加;原发性胆汁性肝硬化患者的纤维蛋白/纤维蛋白原降解产物正常,大胆管梗阻患者中度增加。这些纤溶指标均与胆汁淤积程度无关。在接受研究的3例大胆管梗阻患者中,姑息性手术后纤溶活性和纤维蛋白原几乎恢复到正常水平。血浆纤溶降低和纤维蛋白原增加可能是由于胆汁淤积性黄疸时脂质代谢改变所致。对于接受大胆管梗阻手术的患者,血栓形成风险可能增加。

相似文献

1
Fibrinolysis in cholestatic jaundice.胆汁淤积性黄疸中的纤维蛋白溶解作用。
Br Med J. 1973 Mar 17;1(5854):640-2. doi: 10.1136/bmj.1.5854.640.
2
[Fibrinogen and fibrinolysis in the differential diagnosis of cholestatic viral hepatitis and obstructive jaundice of tumor etiology].
Vrach Delo. 1982 Dec(12):97-100.
3
[Fibrinolysis in chronic liver diseases studied by in vitro blood coagulation tests].[通过体外凝血试验研究慢性肝病中的纤维蛋白溶解]
Orv Hetil. 1994 Dec 18;135(51):2821-4.
4
Plasma fibrinolysis and postoperative deep vein thrombosis.血浆纤维蛋白溶解与术后深静脉血栓形成
Br J Surg. 1976 Sep;63(9):694-7. doi: 10.1002/bjs.1800630906.
5
Impaired fibrinolysis in obstructive jaundice--evidence from clinical and experimental studies.梗阻性黄疸中纤维蛋白溶解功能受损——来自临床和实验研究的证据。
Thromb Haemost. 1988 Aug 30;60(1):25-9.
6
The fibrinolytic enzyme system in acute and chronic liver injury.急性和慢性肝损伤中的纤维蛋白溶解酶系统。
Acta Haematol. 1974;52(5):289-93. doi: 10.1159/000208253.
7
Comparison of the relative fibrinogenolytic, fibrinolytic and thrombolytic properties of tissue plasminogen activator and urokinase in vitro.组织型纤溶酶原激活剂与尿激酶在体外的相对纤维蛋白溶解、纤溶及溶栓特性比较
Thromb Haemost. 1981 Jun 30;45(3):225-9.
8
The fibrinolytic system and postoperative thrombosis following operation of rectal carcinoma. A preliminary report.纤维蛋白溶解系统与直肠癌手术后的术后血栓形成。初步报告。
Acta Chir Scand. 1974;140(5):352-4.
9
[Possibilities of early diagnosis of thromboembolic complications in myocardial infarct by means of biochemical methods].[通过生化方法早期诊断心肌梗死血栓栓塞并发症的可能性]
Kardiologiia. 1977 Jan;17(1):98-103.
10
[Molecular mechanisms of fibrinolysis and perspectives of thrombolytic therapy].[纤维蛋白溶解的分子机制及溶栓治疗的前景]
Vopr Med Khim. 1984 Sep-Oct;30(5):13-22.

引用本文的文献

1
Fibrin deposition following bile duct injury limits fibrosis through an αMβ2-dependent mechanism.胆管损伤后纤维蛋白沉积通过αMβ2依赖性机制限制纤维化。
Blood. 2016 Jun 2;127(22):2751-62. doi: 10.1182/blood-2015-09-670703. Epub 2016 Feb 26.
2
Antithrombin III, plasminogen and alpha 2 antiplasmin in jaundice. Clinical usefulness and prognostic significance.黄疸患者的抗凝血酶III、纤溶酶原和α2抗纤溶酶。临床应用及预后意义。
Gut. 1984 Oct;25(10):1050-6. doi: 10.1136/gut.25.10.1050.
3
Impaired coagulation in the bleeding of chronic liver disease.慢性肝病出血时的凝血功能障碍。
J R Coll Physicians Lond. 1973 Oct;8(1):79-86.
4
Endotoxaemia and renal failure in cirrhosis and obstructive jaundice.肝硬化和梗阻性黄疸中的内毒素血症与肾衰竭
Br Med J. 1976 Dec 11;2(6049):1415-8. doi: 10.1136/bmj.2.6049.1415.
5
Some clinical features of liver cell failure: an appraisal of their causes.肝细胞衰竭的一些临床特征:对其病因的评估。
Gut. 1978 Jun;19(6):543-8. doi: 10.1136/gut.19.6.543.

本文引用的文献

1
DEMONSTRATION OF FIBRINOLYTIC SPLIT PRODUCTS IN HUMAN SERUM BY AN IMMUNOLOGICAL METHOD IN SPONTANEOUS AND INDUCED FIBRINOLYTIC STATES.用免疫方法在自发和诱导纤溶状态下检测人血清中的纤维蛋白溶解分裂产物
Scand J Haematol. 1964;1:313-30. doi: 10.1111/j.1600-0609.1964.tb00029.x.
2
FIBRINOLYTIC ACTIVITY IN PLASMA AND URINE IN CHRONIC RENAL DISEASE.慢性肾病患者血浆和尿液中的纤溶活性
J Clin Pathol. 1964 May;17(3):365-8. doi: 10.1136/jcp.17.3.365.
3
ANTIPLASMIN ACTIVITY OF BETA-LIPOPROTEIN.β-脂蛋白的抗纤溶酶活性
J Atheroscler Res. 1964 Mar-Apr;4:189-92. doi: 10.1016/s0368-1319(64)80039-9.
4
The lipid composition of serum in patients with liver disease.肝病患者血清的脂质成分。
J Clin Invest. 1960 Nov;39(11):1639-50. doi: 10.1172/JCI104187.
5
Severe thrombotic disease in a young man with bone marrow and skeletal changes and with a high content of an inhibitor in the fibrinolytic system.一名年轻男性患有严重血栓性疾病,伴有骨髓和骨骼改变,且纤溶系统中一种抑制剂含量较高。
Acta Med Scand. 1961 Mar;169:323-37. doi: 10.1111/j.0954-6820.1961.tb07838.x.
6
The relationship between blood fibrinolytic activity, serum lipoproteins and serum cholesterol in atherosclerotic arterial disease.
Australas Ann Med. 1960 Aug;9:234-6. doi: 10.1111/imj.1960.9.3.234.
7
The mechanism of clot dissolution by plasmin.纤溶酶溶解血栓的机制。
J Clin Invest. 1959 Jul;38(7):1086-95. doi: 10.1172/JCI103885.
8
Gonadal influences on plasma fibrin and fibrinolytic activity: a possible basis for the further analysis of some forms of coronary thrombosis.性腺对血浆纤维蛋白和纤维蛋白溶解活性的影响:对某些形式冠状动脉血栓形成进行进一步分析的可能基础。
Endocrinology. 1958 Jan;62(1):92-7. doi: 10.1210/endo-62-1-92.
9
The fibrin plate method for estimating fibrinolytic activity.用于评估纤维蛋白溶解活性的纤维蛋白平板法。
Arch Biochem Biophys. 1952 Oct;40(2):346-51. doi: 10.1016/0003-9861(52)90121-5.
10
Fibrin degradation products in sera of normal subjects.正常受试者血清中的纤维蛋白降解产物
Br Med J. 1967 Dec 23;4(5581):718-20. doi: 10.1136/bmj.4.5581.718.